BNP/PUT/ELI LILLY & CO/950/0.1/20.09.24 | Market Closed - Boerse Frankfurt Warrants 15:50:24 2024-07-03 EDT | ||
| 7.27 EUR | +8.18% |
|
| Current month | +11.77% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ELI LILLY AND COMPANY
Latest news about ELI LILLY AND COMPANY
| Date | Price | Change |
|---|---|---|
| 24-07-03 | 7.31 | +8.78% |
| 24-07-02 | 6.72 | +7.01% |
| 24-07-01 | 6.28 | -3.98% |
| 24-06-28 | 6.54 | -2.53% |
| 24-06-27 | 6.71 | -5.23% |
Real-time Boerse Frankfurt Warrants
Last update July 03, 2024 at 03:50 pm
More quotesStatic data
| Product type | Warrants |
|---|---|
| Buy / Sell | PUT |
| Underlying | ELI LILLY AND COMPANY |
| Issuer | 
BNP Paribas
|
| WKN | PG2P38 |
| ISIN | DE000PG2P380 |
| Date issued | 2024-06-14 |
| Strike | 950 $ |
| Maturity | 2024-09-20 (79 Days) |
| Parity | 10 : 1 |
| Emission price | 8.52 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 8.66 € |
|---|---|
| Lowest since issue | 6 € |
| Delta | -0.61x |
| Omega | 6.883 |
| Premium | 3.02x |
| Gearing | 11.37x |
| Moneyness | 1.058 |
| Difference Strike | 51.9 $ |
| Difference Strike % | +5.46% |
| Spread | 0.11 € |
| Spread % | 1.49% |
| Theoretical value | 7.315 |
| Implied Volatility | 31.70 % |
| Total Loss Probability | 34.95 % |
| Intrinsic value | 4.812 |
| Present value | 2.503 |
| Break even | 871.10 € |
| Theta | -0.17x |
| Vega | 0.15x |
| Rho | -0.09x |
Company Profile
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows:
- endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems;
- oncology (19.5%);
- immunology diseases (11.1%);
- neurology (8.4%): primarily drugs used in treating depression and schizophrenia;
- other (3.3%).
Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
Consensus: Eli Lilly and Company
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
898.1
USD
Average target price
870.3
USD
Spread / Average Target
-3.10%
- Stock Market
- Warrants
- Warrant
